Market Tracker

08/16 5:16pm ET

Celgene Corp (NASDAQ:CELG)

131.26
Delayed Data
As of Aug 16
 -0.11 / -0.08%
Today’s Change
96.93
Today|||52-Week Range
139.00
+13.40%
Year-to-Date
Biotech Stock Roundup: Regeneron Drops RSV Antibody, Gilead HIV Drug Gets Priority Re...
Aug 16 / Zacks.com - Paid Partner Content
Fcg Advisors, Llc Buys Celgene Corp, Guggenheim BulletShares 2019 Corporate Bond, Pow...
Aug 10 / GuruFocus News - Paid Partner Content
Be Cautious in Case of a Second-Half Hiccup
Aug 14 / TheStreet.com - Paid Partner Content
Agios (AGIO) Q2 Loss Wider than Expected, Revenues Up Y/Y
Aug 09 / Zacks.com - Paid Partner Content
Back to Basics in Biotech
Aug 13 / TheStreet.com - Paid Partner Content
Biotech Stock Roundup: Q2 Earnings from Regeneron, Kite & More, FibroGen Up on IPF Da...
Aug 09 / Zacks.com - Paid Partner Content
Back to Basics in Biotech
Aug 11 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close131.37
Today’s open131.77
Day’s range130.38 - 132.12
Volume2,219,882
Average volume (3 months)3,734,836
Market cap$102.8B
Dividend yield--
Data as of 4:00pm ET, 08/16/2017

Growth & Valuation

Earnings growth (last year)+28.35%
Earnings growth (this year)+23.17%
Earnings growth (next 5 years)+21.84%
Revenue growth (last year)+22.70%
P/E ratio40.8
Price/Sales8.51
Price/Book15.50

Competitors

 Today’s
change
Today’s
% change
GSKGlaxoSmithKline+0.29+0.74%
BMYBristol-Myers Squibb-0.37-0.64%
ABBVAbbVie+0.08+0.11%
LLYEli Lilly and Co-1.02-1.25%
Data as of 4:02pm ET, 08/16/2017

Financials

Next reporting dateOctober 26, 2017
EPS forecast (this quarter)$1.88
Annual revenue (last year)$10.9B
Annual profit (last year)$2.0B
Net profit margin18.30%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mark J. Alles
President &
Chief Operating Officer
Scott Andrew Smith
Corporate headquarters
Summit, New Jersey

Forecasts